ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Neurology

Top Neurology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ERFAN ALBAKRI MD

Neurology

2,181

$250K

315
228 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$114
Average prescription price

Avg: $204

DANIEL STEIN MD

Neurology

866

$609K

163
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$704
Average prescription price

Avg: $204

RICHARD SINGER MD

Neurology

3,175

$548K

469
384 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$172
Average prescription price

Avg: $204

JOHN CINTRON M.D

Neurology

9,049

$901K

1545
1348 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$100
Average prescription price

Avg: $204

RICHARD BAILYN M.D.

Neurology

1,350

$228K

198
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 27%

$169
Average prescription price

Avg: $204

DAVID MALKA MD

Neurology

1,220

$316K

223
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$259
Average prescription price

Avg: $204

GREGORY HANES MD

Neurology

1,403

$221K

269
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$158
Average prescription price

Avg: $204

ALVARO LACAYO MD

Neurology

4,412

$604K

257
199 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 27%

$137
Average prescription price

Avg: $204

MARK RUBINO MD

Neurology

2,633

$495K

171
105 are 65+

32%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$188
Average prescription price

Avg: $204

INDIRA UMAMAHESWARAN MD

Neurology

795

$261K

115
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 27%

$329
Average prescription price

Avg: $204

LARA KATZIN M.D.

Neurology

971

$910K

116
71 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 27%

$937
Average prescription price

Avg: $204

TRACEY CERBONE M.D.

Neurology

2,668

$479K

311
246 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$179
Average prescription price

Avg: $204

ABRAHAM CHAMELY MD

Neurology

3,572

$594K

453
361 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$166
Average prescription price

Avg: $204

GLEN FINNEY MD

Neurology

958

$237K

151
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 27%

$248
Average prescription price

Avg: $204

CHRISTOPHER PRUSINSKI DO

Neurology

598

$75.7K

93
52 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 27%

$127
Average prescription price

Avg: $204

SALEEM KHAMISANI M.D.

Neurology

2,281

$536K

286
165 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$235
Average prescription price

Avg: $204

JULIETTE COLEMAN MD

Neurology

2,430

$386K

308
251 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$159
Average prescription price

Avg: $204

RALPH ZWOLINSKI MD

Neurology

990

$144K

199
88 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$146
Average prescription price

Avg: $204

ROBERT HAUSER MD

Neurology

2,040

$579K

217
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$284
Average prescription price

Avg: $204

GALINA BOGORODSKAYA MD

Neurology

1,901

$254K

205
128 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$134
Average prescription price

Avg: $204

DANIEL BELL M.D.

Neurology

1,463

$500K

239
191 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$342
Average prescription price

Avg: $204

BARRY CUTLER MD

Neurology

2,999

$891K

435
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$297
Average prescription price

Avg: $204

DANIEL TRAVIESA MD

Neurology

2,676

$743K

382
314 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$278
Average prescription price

Avg: $204

DAVID BEAR D.O.

Neurology

2,667

$570K

301
173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$214
Average prescription price

Avg: $204

HASAN MOUSLI MD

Neurology

4,741

$339K

436
217 are 65+

23%
patients receiving schedule two controlled substances

Avg: 4%

40%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $204

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank